Vanguard Group’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Buy |
|
|||||
|
2025
Q1 | $23.1M | Sell |
|
|||||
|
2024
Q4 | $86.6M | Sell |
|
|||||
|
2024
Q3 | $90.8M | Buy |
|
|||||
|
2024
Q2 | $141M | Buy |
|
|||||
|
2024
Q1 | $170M | Buy |
|
|||||
|
2023
Q4 | $183M | Buy |
|
|||||
|
2023
Q3 | $143M | Buy |
|
|||||
|
2023
Q2 | $158M | Sell |
|
|||||
|
2023
Q1 | $158M | Buy |
|
|||||
|
2022
Q4 | $183M | Buy |
|
|||||
|
2022
Q3 | $150M | Buy |
|
|||||
|
2022
Q2 | $167M | Buy |
|
|||||
|
2022
Q1 | $168M | Sell |
|
|||||
|
2021
Q4 | $157M | Buy |
|
|||||
|
2021
Q3 | $176M | Sell |
|
|||||
|
2021
Q2 | $179M | Sell |
|
|||||
|
2021
Q1 | $176M | Sell |
|
|||||
|
2020
Q4 | $181M | Buy |
|
|||||
|
2020
Q3 | $142M | Sell |
|
|||||
|
2020
Q2 | $169M | Buy |
|
|||||
|
2020
Q1 | $165M | Sell |
|
|||||
|
2019
Q4 | $221M | Sell |
|
|||||
|
2019
Q3 | $144M | Buy |
|
|||||
|
2019
Q2 | $171M | Sell |
|
|||||
|
2019
Q1 | $202M | Buy |
|
|||||
|
2018
Q4 | $138M | Buy |
|
|||||
|
2018
Q3 | $228M | Buy |
|
|||||
|
2018
Q2 | $228M | Buy |
|
|||||
|
2018
Q1 | $177M | Buy |
|
|||||
|
2017
Q4 | $169M | Buy |
|
|||||
|
2017
Q3 | $174M | Buy |
|
|||||
|
2017
Q2 | $203M | Buy |
|
|||||
|
2017
Q1 | $179M | Buy |
|
|||||
|
2016
Q4 | $152M | Buy |
|
|||||
|
2016
Q3 | $153M | Buy |
|
|||||
|
2016
Q2 | $123M | Buy |
|
|||||
|
2016
Q1 | $99.5M | Buy |
|
|||||
|
2015
Q4 | $102M | Buy |
|
|||||
|
2015
Q3 | $89.1M | Buy |
|
|||||
|
2015
Q2 | $100M | Buy |
|
|||||
|
2015
Q1 | $128M | Buy |
|
|||||
|
2014
Q4 | $116M | Buy |
|
|||||
|
2014
Q3 | $94.8M | Buy |
|
|||||
|
2014
Q2 | $110M | Buy |
|
|||||
|
2014
Q1 | $88M | Buy |
|
|||||
|
2013
Q4 | $65.8M | Buy |
|
|||||
|
2013
Q3 | $65.1M | Buy |
|
|||||
|
2013
Q2 | $51.3M | Buy |
|